Is XPHY.CN undervalued or overvalued?

As of 2025-03-27, the Intrinsic Value of Xphyto Therapeutics Corp (XPHY.CN) is (2.54) CAD. This XPHY.CN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.50 CAD, the upside of Xphyto Therapeutics Corp is -612.30%. This means that XPHY.CN is overvalued by 612.30%.

The range of the Intrinsic Value is (5.62) - (1.70) CAD

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(5.62) - (1.70)	(2.54)	-612.3%
DCF (Growth 10y)	(1.73) - (5.22)	(2.49)	-602.6%
DCF (EBITDA 5y)	(0.58) - (0.74)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(0.93) - (1.17)	(1,234.50)	-123450.0%
Fair Value	-1.10 - -1.10	-1.10	-321.48%
P/E	(0.88) - (1.25)	(1.08)	-317.2%
EV/EBITDA	(0.08) - (0.14)	(0.11)	-123.2%
EPV	(1.12) - (1.62)	(1.37)	-376.7%
DDM - Stable	(1.12) - (5.17)	(3.14)	-734.6%
DDM - Multi	(1.18) - (4.45)	(1.89)	-481.9%